Pioneering β-Glucan Research
Since 1962
For over sixty years, we have led deep research into β-glucans, decoding the complex mechanisms that regulate the tumor microenvironment. We blend historical experience with modern biotechnology to provide professional-grade, evidence-based solutions that help the immune system fight cancer with precision and efficiency.
Legacy of Excellence
Decades of β-Glucan Innovation
Since 1962, our institution has led deep research into the role of β-glucans in oncology. By decoding the molecular pathways that activate innate immunity, we combine sixty years of clinical tradition with cutting-edge biotechnology. Our professional commitment remains unwavering: to master the science of immunomodulation and bring targeted, evidence-based breakthroughs to patients worldwide.
Unleashing the Power of Immunomodulation
Simplicity in Design and Form
Based on sixty years of clinical practice, our research reveals the intricate mechanisms of β-glucans in oncology. By binding to specific receptors on innate immune cells, it bridges the gap between recognition and destruction of malignant tissue. We focus on the deep activation of macrophages and natural killer (NK) cells, transforming the immunosuppressive tumor microenvironment into an active defense mechanism.
Our Team
Our outstanding team is at your service.
Peter Stark
PhD & Principal Investigator
Six Decades of Precision, Reimagining the Immune Frontier. To our global community, since our lab first embarked on the scientific journey of β-glucan research in 1962, the field of oncology has undergone fundamental transformation. Yet, our core pursuit remains unwavering: to master the art of awakening the body's innate intelligence to fight cancer.
Bjorn Gunnarsson
PhD & Researcher
In the past sixty years, we transformed from basic isolation techniques to advanced molecular engineering. Our "Deep Research" philosophy means we are not satisfied with superficial results. We study the granular interaction between β-glucan and cell receptors, ensuring our treatments are both biologically sound and clinically transformative.
Charlotte Banks
R&D
We are not just discussing an ingredient; we are advancing a precise mechanism for activating the immune system. Through deep molecular research into receptors like Dectin-1, we have elevated β-glucan from a vague "natural extract" to the rigorous level of precise immunomodulation.
Sam Gallagher
Customer Support
We understand that behind every trust is a family. Therefore, our reverence for science remains as pure and steadfast as that first morning of exploration in 1962.